Alhemo
Concizumab · Novo Nordisk
PRESCRIPTION ONLY (USA)Alhemo ingredients
| Active ingredient | Strength |
|---|---|
| Concizumab | 40 mg/mL, 100 mg/mL |
What Alhemo is used for
Alhemo is a specialist medicine (tissue factor pathway inhibitor antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Alhemo
- Generic name
- Concizumab
- Made by
- Novo Nordisk
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- Tissue Factor Pathway Inhibitor Antagonist
- FDA approval
- Biologic licence (BLA) BLA761315
- On the US market since
- 2025
Official information
- Alhemo prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Concizumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Alhemo?
Alhemo (Concizumab) is a specialist medicine made by Novo Nordisk, approved by the US FDA.
What are the ingredients of Alhemo?
Alhemo contains Concizumab (40 mg/mL, 100 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA